Literature DB >> 25993717

Short-long-short sequence-induced torsade de pointes after transcatheter aortic-valve implantation.

Kevser Gülcihan Balcı1, Mustafa Mücahit Balcı, Samet Yılmaz, Orhan Maden.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 25993717      PMCID: PMC5779183          DOI: 10.5152/akd.2015.6120

Source DB:  PubMed          Journal:  Anatol J Cardiol        ISSN: 2149-2263            Impact factor:   1.596


× No keyword cloud information.

Introduction

The gold-standard treatment of symptomatic aortic stenosis (AS) is surgical aortic-valve replacement (SAVR); however, many patients owing to high operative risks are not candidates for this treatment (1). Hence, transcatheter aortic-valve implantation (TAVI) was introduced to be an alternative modality to SAVR. Because of older patient population and structural heart disease, TAVI patients may have proarrhythmic tendencies related to electrolyte imbalances and drug-drug interactions. Among patients with pacemakers, implantable cardioverter-defibrillators (ICD), and cardiac resynchronization therapy (CRT) receivers, the proarrhythmic effect of pacing was described earlier (2-4). Torsades de pointes (TdP) is a polymorphic ventricular tachycardia in the setting of a prolonged QTc interval (5); however, pacing related episodes and triggered activity related TdP in AS patients were cited in several reports (2-4, 6, 7). This report describes a 78-year-old patient being VVI paced, who experienced a short-long-short sequence-induced TdP without QT prolongation in intensive care unit after TAVI.

Case Report

Seventy-eight-year-old female was admitted to the hospital with progressive dyspnea. She underwent pacemaker implantation two months ago because of an intermittent third-degree atrioventricular block. The initial transthoracic echocardiography (TTE) revealed severe AS (mean gradient, 50 mm Hg; aortic-valve area, 0.8 cm2) and mild aortic regurgitation with normal ejection fraction (65%). The heart team decided to perform TAVI via a trans-femoral approach utilizing a 29-mm CoreValve (Medtronic, Minneapolis, MN) successfully 3 days after coronary intervention. Post-procedural TTE showed a well-functioning bioprosthetic valve and mild aortic insufficiency. On the post-procedural third day, ventricular extrasystoles (VES) with short-long-short sequences and non-sustained ventricular tachycardia (VT) with right bundle branch block pattern (RBBB) were seen on the monitor (Fig. 1). The patient later experienced TdP (Fig. 2). Following 300 J defibrillation, regular rhythm was maintained. There was no QT prolongation (QT=420 milliseconds) and pacemaker malfunction, and her electrolytes were within normal limits. She had no ischemic symptoms or electrocardiogram (ECG) abnormalities. Although we increased pacemaker basic rate to 80 beat/minute, because of the absence of a conclusive cause of TdP, the heart team decided to upgrade the pacemaker to a dual chamber pacemaker—defibrillator (DDD-ICD) as it would be safer for the patient. The patient was discharged from the hospital after 2 days of ICD implantation with good clinical condition.
Figure 1

Morphology of ventricular extra-systoles and ventricular tachycardia indicate the origin of arrhythmia from left ventricular outflow tract

Figure 2

a-c. Short-long-short sequence (a, b). Torsade de pointes (c)

Discussion

In the elderly population, AS is a common medical problem. Patients with severe symptomatic AS with high risk profile are candidates for TAVI and tend to be older than those who undergo SAVR. Therefore, they may be more susceptible to arrhythmias. Not only treating the underlying heart condition, but also the post-procedural care of the older patients and managing the complications may be important for the outcome. Morphology of ventricular extra-systoles and ventricular tachycardia indicate the origin of arrhythmia from left ventricular outflow tract a-c. Short-long-short sequence (a, b). Torsade de pointes (c) Most common arrhythmias are bradycardia and atrioventricular block after TAVI, and it has been shown that approximately every 7th patient undergoing TAVI requires a permanent pacemaker after the procedure (8). Tachycardia is unusual and there are a few case reports presenting VT after TAVI procedure in the literature (9, 10). However, our case is the first one presenting TdP after TAVI. In our case, the origin of VES and VT were most probably the left ventricular outflow tract (LVOT) because of RBBB morphology in ECG. Patient underwent pacemaker implantation two months before TAVI. Before pacemaker implantation, the rate of the idioventricular rhythm was 30/minute, and QT was 470 milliseconds. In our case, after pacemaker implantation, the measured QT interval was 420 milliseconds at a rate of 65 beats/minute; however, the right ventricular apex pacing could disguise left ventricular electrical remodeling as well as QT prolongation, which may enhance the susceptibility for arrhythmias in such patients. Furthermore, in AS patients, hypertrophic myocardium may generate the substrate for arrhythmias via triggered activity (6). Vos et al. (7) showed that six weeks after creating a complete AV block in the dog leads to electrical remodeling due to the altered electrophysiological properties of the hypertrophic myocardium and subsequently an arrhythmogenic susceptibility. Short-long-short sequences that led to TdP may have been the manifestation of triggered activity in our case. Therefore, we performed DDD-ICD implantation for the prevention of sudden cardiac death.

Conclusion

In this case, we emphasize the precise care of post-procedural TAVI patients. They are older and fragile; therefore, may be the candidates for arrhythmias. Despite the treatment of severe AS with either TAVI or surgery, a tendency toward arrhythmia may remain as the reverse remodeling process continues. Even after a successful intervention, an unexpected death can occur due to malignant arrhythmias.
  10 in total

1.  Left-ventricular outflow tract ventricular-tachycardia event following CoreValve transcatheter aortic-valve implantation.

Authors:  Danny Dvir; Moti Haim; Ran Kornowski
Journal:  Catheter Cardiovasc Interv       Date:  2011-12-07       Impact factor: 2.692

2.  Torsade de pointes: an electrophysiological effect of cardiac resynchronization?

Authors:  Gioia Turitto; Salman Haq; David Benson; Nabil El-Sherif
Journal:  Pacing Clin Electrophysiol       Date:  2006-05       Impact factor: 1.976

3.  Pacemaker pro-arrhythmia: beyond spike-on-T and endless loop tachycardia.

Authors:  John D Fisher
Journal:  J Am Coll Cardiol       Date:  2007-07-30       Impact factor: 24.094

4.  Ventricular tachycardia following trans-apical aortic valve replacement.

Authors:  Roy Beinart; Stephan Danik; Igor Palacios; Conor Barrett; Ignacio Inglessis; Arvind Agnihotri; Jonathan Passeri
Journal:  Europace       Date:  2011-10-19       Impact factor: 5.214

Review 5.  Risk for permanent pacemaker after transcatheter aortic valve implantation: a comprehensive analysis of the literature.

Authors:  Damir Erkapic; Salvatore De Rosa; Augustin Kelava; Ralf Lehmann; Stephan Fichtlscherer; Stefan H Hohnloser
Journal:  J Cardiovasc Electrophysiol       Date:  2011-11-03

Review 6.  Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation.

Authors:  Barbara J Drew; Michael J Ackerman; Marjorie Funk; W Brian Gibler; Paul Kligfield; Venu Menon; George J Philippides; Dan M Roden; Wojciech Zareba
Journal:  J Am Coll Cardiol       Date:  2010-03-02       Impact factor: 24.094

7.  Enhanced susceptibility for acquired torsade de pointes arrhythmias in the dog with chronic, complete AV block is related to cardiac hypertrophy and electrical remodeling.

Authors:  M A Vos; S H de Groot; S C Verduyn; J van der Zande; H D Leunissen; J P Cleutjens; M van Bilsen; M J Daemen; J J Schreuder; M A Allessie; H J Wellens
Journal:  Circulation       Date:  1998-09-15       Impact factor: 29.690

8.  Torsades de pointes as a cause of sudden death in a patient with aortic stenosis and atrial fibrillation.

Authors:  Polychronis Dilaveris; Charalambos Vassilopoulos; Evaggelia Tsagga; Manolis Vavuranakis; Christodoulos Stefanadis
Journal:  Ann Noninvasive Electrocardiol       Date:  2006-07       Impact factor: 1.468

9.  Bradycardia pacing-induced short-long-short sequences at the onset of ventricular tachyarrhythmias: a possible mechanism of proarrhythmia?

Authors:  Michael O Sweeney; Linda L Ruetz; Paul Belk; Thomas J Mullen; James W Johnson; Todd Sheldon
Journal:  J Am Coll Cardiol       Date:  2007-07-30       Impact factor: 24.094

Review 10.  Advanced age and the clinical outcomes of transcatheter aortic valve implantation.

Authors:  Osama Alsara; Ahmad Alsarah; Heather Laird-Fick
Journal:  J Geriatr Cardiol       Date:  2014-06       Impact factor: 3.327

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.